Recurrent thrombosis and lupus anticoagulant in systemic lupus erythematosus. 1986

F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D016682 Lupus Coagulation Inhibitor An antiphospholipid antibody found in association with a variety of diseases (e.g., SYSTEMIC LUPUS ERYTHEMATOSUS and ANTIPHOSPHOLIPID SYNDROME) as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications. Lupus Anticoagulant,Lupus Anticoagulant Autoantibodies,Lupus Anticoagulant Autoantibody,Anticoagulant, Lupus,Coagulation Inhibitor, Lupus,Inhibitor, Lupus Coagulation,Anticoagulant Autoantibody, Lupus,Autoantibody, Lupus Anticoagulant

Related Publications

F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
March 1984, Lancet (London, England),
F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
January 1987, The American journal of the medical sciences,
F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
October 1981, Orvosi hetilap,
F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
January 1984, Clinical and experimental rheumatology,
F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
March 1981, American journal of diseases of children (1960),
F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
May 1990, Revista clinica espanola,
F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
January 1989, Acta dermato-venereologica,
F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
January 1991, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
October 1983, British medical journal (Clinical research ed.),
F Lioté, and T Hannedouche, and O Meyer, and M D Dautzenberg, and P Jungers
October 1986, The Journal of rheumatology,
Copied contents to your clipboard!